Evenemang
Protein and Peptide Conference- 2012
2012-02-07 09:03
Tid: 2012-03-23 - 2012-03-25
Plats:
Beijing, China
Kategorisering
- Ämnen:
- Medicin,
- Medicinsk forskning,
- Vetenskap, teknik
- Tags:
- teodor aastrup,
- cell,
- label free,
- kinetics,
- biotech,
- attana cell 200,
- biosensor,
- antibodies,
- attana,
- protein and peptide
- Typ av evenemang:
- Konferenser och kongresser,
- Seminarium
Relaterade nyheter
2011-11-16 09:30 One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.
Relaterade evenemang
2011-03-07 09:00 Attana will be participating at the International Congress of Antibodies in Beijing and present on several topics: "In Vitro Evolution of Allergy Vaccine Candidates with Reduced IgE-Binding and T-Cell Activation Capacity" - Ola B Nilsson and the Karolinska Institute "Kinetics on Cells - Bridging the Gap Between Traditional Biosensors and Cell-Based Assays" - Samuel Altun, Cell Application...
Tid: 2011-03-23 - 2011-03-25
Plats:
Beijing, China
Relaterade bilder
2010-04-07 15:01 The Attana Cell 200 enables kinetic characterization of interactions on intact cells, in real time. Cells can be cultivated directly on Attana’s proprietary cell surface or captured from cell suspension before analysis.
Relaterade videor
2011-01-14 09:00
The Attana Cell 200 biosensor has the unique ability to determine label-free kinetics directly on the cell surface, therefore disclosing the full complexity of the interaction at a very early stage. By delivering biologically relevant information this early in the research process, The Attana Cell 200 minimizes costs and increases success during clinical trials.(produced by TTV AB)
Längd 1:24
Lägg till kommentarKommentaren sparades
Innan den publiceras måste den godkännas av Attana AB.